stage iv breast cancer

Showing 1 - 25 of 167

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HER2-positive Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Miami (Discontinuation of Anti-HER-2 Maintenance

Recruiting
  • HER2-positive Metastatic Breast Cancer
  • Stage IV Breast Cancer
  • Discontinuation of Anti-HER-2 Maintenance Treatment
  • Miami, Florida
    University of Miami
Jul 17, 2023

Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Marietta, East Brunswick (Sacituzumab

Recruiting
  • Locally Advanced or Unresectable Metastatic Breast Cancer
  • Stage IV Breast Cancer
  • Sacituzumab Govitecan-hziy
  • +3 more
  • Marietta, Georgia
  • +1 more
Apr 21, 2023

Breast Cancer Trial in Worldwide (palliative surgery, therapeutic conventional surgery, palliative radiation therapy)

Completed
  • Breast Cancer
  • Stage IV Breast Cancer
  • palliative surgery
  • +3 more
  • Mobile, Alabama
  • +376 more
Jan 6, 2023

Carcinoma, Ductal, Breast, Breast Cancer Female, Breast Tumor Trial in Worldwide (G1T48, Palbociclib)

Completed
  • Carcinoma, Ductal, Breast
  • +6 more
  • Beverly Hills, California
  • +14 more
Dec 14, 2022

Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)

Completed
  • Male Breast Cancer
  • +7 more
  • propranolol hydrochloride
  • Correlative Studies
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 4, 2022

Triple Negative Breast Cancer, Stage IV Breast Cancer, HER2 Negative Trial in United States (Atezolizumab, Carboplatin,

Active, not recruiting
  • Triple Negative Breast Cancer
  • +3 more
  • Washington, District of Columbia
  • +5 more
Dec 1, 2022

HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle

Active, not recruiting
  • HER2-positive Breast Cancer
  • +8 more
  • pNGVL3-hICD vaccine
  • +6 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022

HER2 Positive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer Trial in Palo Alto (Utomilumab, Trastuzumab,

Completed
  • HER2 Positive Breast Carcinoma
  • +6 more
  • Palo Alto, California
    Stanford University, School of Medicine
Sep 22, 2022

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma Trial in Boston,

Active, not recruiting
  • Estrogen Receptor-positive Breast Cancer
  • +5 more
  • PI3K inhibitor BYL719
  • +3 more
  • Boston, Massachusetts
  • +1 more
Oct 14, 2022

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)

Terminated
  • Estrogen Receptor Positive
  • +16 more
  • Biopsy of Breast
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 22, 2022

Defining Clinical Potential of Mass Response asBiomarker for

Recruiting
  • Stage III Breast Cancer
  • +5 more
    • Columbus, Georgia
      Columbus Regional Research Institute, John B. Amos Cancer Center
    Jul 13, 2022

    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer Trial in

    Terminated
    • Estrogen Receptor-positive Breast Cancer
    • +7 more
    • Atlanta, Georgia
    • +2 more
    Mar 10, 2022

    Breast Cancer, Breast Adenocarcinoma, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Bronx (Rebastinib,

    Terminated
    • Breast Cancer
    • +4 more
    • Bronx, New York
      Montefiore Medical Center
    Mar 23, 2022

    HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IIA Breast Cancer Trial in Duarte, Lancaster, South Pasadena

    Active, not recruiting
    • HER2-positive Breast Cancer
    • +9 more
    • pertuzumab
    • +3 more
    • Duarte, California
    • +2 more
    Mar 17, 2022

    Solid Tumor, Stage III Pancreatic Cancer, Stage IIIA Breast Cancer Trial in Atlanta (Carboplatin, Cisplatin, Palbociclib)

    Active, not recruiting
    • Solid Neoplasm
    • +16 more
    • Atlanta, Georgia
      Emory University/Winship Cancer Institute
    Feb 28, 2022

    HER2 Negative Breast Carcinoma, Recurrent Breast Carcinoma, Stage IIIA Breast Cancer Trial in Seattle

    Recruiting
    • HER2 Negative Breast Carcinoma
    • +6 more
    • CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
    • Laboratory Biomarker Analysis
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Feb 18, 2022

    Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Biomarker Analysis,

    Active, not recruiting
    • Estrogen Receptor Negative
    • +6 more
    • Biomarker Analysis
    • +3 more
    • Birmingham, Alabama
    • +8 more
    Feb 3, 2022

    Stage IV Breast Cancer Trial in Roma (Stereotactic Body Radiation Therapy (SBRT))

    Recruiting
    • Stage IV Breast Cancer
    • Stereotactic Body Radiation Therapy (SBRT)
    • Roma, Italy
      Università Campus Biomedico
    Feb 4, 2022

    Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +66 more
    • Best Practice
    • +3 more
    • Fullerton, California
      Virginia K Crosson Cancer Center
    Jan 31, 2022

    Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer Trial in Aurora (Omega-3 fatty acid, Celecoxib)

    Active, not recruiting
    • Stage IA Breast Cancer
    • +6 more
    • Aurora, Colorado
      University of Colorado Cancer Center
    Jan 14, 2022

    Treating Patients With Stage IV Breast Cancer

    Active, not recruiting
    • Central Nervous System Metastases
    • +15 more
    • hyperfractionated radiation therapy
    • +2 more
    • North Chicago, Illinois
      University of Chicago
    Dec 6, 2021

    Febrile Neutropenia, Stage 0 Breast Cancer, Stage 0 Colorectal Cancer Trial in Puerto Rico, United States (Preventive

    Completed
    • Febrile Neutropenia
    • +27 more
    • Preventive Intervention
    • +2 more
    • Jonesboro, Arkansas
    • +159 more
    Dec 22, 2021

    Comprehensive Gene Sequencing in Guiding Treatment

    Completed
    • Recurrent Breast Cancer
    • +7 more
    • cytology specimen collection procedure
    • laboratory biomarker analysis
    • Columbus, Ohio
      Arthur G. James Cancer Hospital and Solove Research Institute at
    Oct 21, 2021

    Stage II Breast Cancer, Stage III Breast Cancer, Stage IV Breast Cancer Trial in United States (Behavioral Intervention)

    Recruiting
    • Stage II Breast Cancer
    • +22 more
    • Behavioral Intervention
    • Bay City, Michigan
    • +7 more
    Sep 29, 2021